Candriam SCA’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8M Buy
43,200
+7,458
+21% +$1.98M 0.09% 197
2026
Q1
$3.92M Sell
35,742
-23,838
-40% -$3.4M 0.02% 429
2025
Q4
$9.91M Buy
59,580
+15,880
+36% +$2.66M 0.05% 269
2025
Q3
$8.56M Buy
43,700
+102
+0.2% +$16.8K 0.04% 294
2025
Q2
$3.94M Buy
+43,598
New +$3.44M 0.02% 393

Other funds holding ALAB

Candriam SCA's ALAB Position: Q2 2026 in Review

Candriam SCA increased its Astera Labs (ALAB) stake by 21% in Q2 2026, buying an estimated $1.98M and bringing the position to 43,200 shares worth $20.8M. The position accounts for 0.09% of the portfolio, ranked #197.

Candriam SCA first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Candriam SCA held 43,200 shares of Astera Labs worth $20.8M as of Q2 2026.
  • Candriam SCA bought 7,458 Astera Labs shares in Q2 2026, an estimated $1.98M.
  • Astera Labs made up 0.09% of Candriam SCA's portfolio in Q2 2026, its #197 holding.
  • Candriam SCA first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.